Na Liu

Author PubWeight™ 6.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.	PLoS One	2013	1.26
2	Suramin alleviates glomerular injury and inflammation in the remnant kidney.	PLoS One	2012	0.85
3	Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.	J Pharmacol Exp Ther	2011	0.84
4	Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.	J Am Soc Nephrol	2015	0.84
5	Autophagy in Chronic Kidney Diseases.	Kidney Dis (Basel)	2016	0.79
6	Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis.	Oncotarget	2016	0.75
7	Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy.	J Diabetes Res	2017	0.75
8	Epigenetic Regulations in Diabetic Nephropathy.	J Diabetes Res	2017	0.75
9	Nintedanib,a triple tyrosine kinase inhibitor,attenuates renal fibrosis in chronic kidney disease.	Clin Sci (Lond)	2017	0.75
10	Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis.	Oncotarget	2017	0.75